Evidence map›Paper›PMID 38393515›Full record

Trial reportOdontology2024

Clinical evaluation of posterior flowable short fiber-reinforced composite restorations without proximal surface coverage.

Rawda H Abd ElAziz, Sherifa A Abd ElAziz, Possy M Abd ElAziz, Mark Frater, Pekka K Vallittu, Lippo Lassila, Sufyan Garoushi

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Odontology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06924047 (The Clinical Performance of Two Dentine Replacement Materials in Deep Occlusal Cavities), which is not on this map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06924047 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

The Clinical Performance of Two Dentine Replacement Materials in Deep Occlusal Cavities: A Randomized Clinical Trial

TypeinterventionalSponsorDalia Sameh FawziRan2025 to 2026Enrolled50ConditionsClass I Cavities in High Caries Risk, Class I Composite Restorations, Randomized Clinical Trial, Occlusal CariesArmsBeautifil Flow Plus X, EverX Flow
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Clinical performance of different composite materials in class II cavities bonded with universal adhesives.Journal of esthetic and restorative dentistry : official publication of the American Academy of Esthetic Dentistry ... [et al.] · 2025
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rawda H Abd ElAzizConservative Dentistry Department, Faculty of Dentistry, Cairo University, Cairo, Egypt.
Sherifa A Abd ElAzizConservative Dentistry Department, Faculty of Dentistry, Cairo University, Cairo, Egypt.
Possy M Abd ElAzizConservative Dentistry Department, Faculty of Dentistry, Cairo University, Cairo, Egypt.
Mark FraterDepartment of Operative and Esthetic Dentistry, Faculty of Dentistry, University of Szeged, Szeged, Hungary.
Pekka K VallittuDepartment of Biomaterials Science and Turku Clinical Biomaterials Center-TCBC, Institute of Dentistry, University of Turku, Itäinen Pitkäkatu 4B, 20520, Turku, Finland.
Lippo LassilaDepartment of Biomaterials Science and Turku Clinical Biomaterials Center-TCBC, Institute of Dentistry, University of Turku, Itäinen Pitkäkatu 4B, 20520, Turku, Finland.
Sufyan Garoushi *Department of Biomaterials Science and Turku Clinical Biomaterials Center-TCBC, Institute of Dentistry, University of Turku, Itäinen Pitkäkatu 4B, 20520, Turku, Finland. sufgar@utu.fi.ORCID http://orcid.org/0000-0001-9457-2314

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this clinical trail was to assess the clinical behavior of posterior composite restorations supported by a substantial foundation of flowable short fiber-reinforced composite SFRC (everX Flow, GC, Japan) used without proximal surface coverage with particulate filler resin composite (PFC). Seventy patients (20 males, 50 females; mean age: 30 ± 10 years) were randomly enrolled in this trial. Patients received direct restorations of either SFRC covered only on the occlusal surface (1-2 mm) by conventional PFC composite (G-ænial Posterior, GC), or plain conventional PFC composite without fiber-reinforcement, in Class II cavities in premolar and molar vital teeth. One operator made all restorations using one-step, self-etch bonding agent (G-ænial Bond, GC) according to manufacturers' recommendations. Two blinded trained operators evaluated the restorations at baseline, at 6, 12 and 18 months using modified USPHS criteria. Results indicated that, in both groups and at different follow-up intervals, according to evaluated criteria, restorations were rated mostly with best score (Alpha) (p > 0.05). For the marginal integrity after 6 months, a single case in the intervention [increased to 3 (8.8%) after 18 months] and 3 (9.7%) cases of the control group [increased to 4 (12.9%) after 18 months] had Bravo score but with no significant difference (p > 0.05). For color match measured after 6 and 18 months, three (8.8%) cases had Bravo score in the intervention group. The use of flowable SFRC composite without any PFC surface coverage proximally in Class II restorations demonstrated satisfactory clinical outcome throughout the 18-month follow-up.

Indexed as

Composite ResinsDental Restoration, PermanentSurface PropertiesAdultBicuspidDental Marginal AdaptationDentin-Bonding AgentsFemaleHumansMaleMolarTreatment OutcomeComposite ResinsDentin-Bonding AgentsEverX PosteriorG-aenial BondClass IIEverX flowRandomized clinical studyShort fiber-reinforced composites

Identifiers

PMID38393515
PMCPMC11415407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.